Table 2.
Emax and EC50 values in WT and Fbn1mgR/mgR (MFS) mice at indicated age
| Stimulus | Emax | Statistic |
|---|---|---|
| ACh | P16 MFS 91.6±1.49 versus P16 WT 97.9±0.52% | T test, p = 0.0016 |
| ACh | P30 MFS 84.5±3.41 versus P30 WT 99.5±0.31% | T test, p = 0.0006 |
| ACh | P30 MFS 84.5±3.41 versus P16 MFS 91.6±1.49% | T test, p = 0.0357 |
| SNP | P16 MFS 99.0±1.60 versus P16 WT 100±0.00% | T test, p = 0.0762 |
| SNP | P30 MFS 99.7±0.75 versus P30 WT 99.2±0.27% | T test, p = 0.6055 |
| PE | P16 MFS 0.39±0.04 versus P16 WT 0.24±0.03 g/mg wet tissue | T test, p = 0.0311 |
| PE | P30 MFS 1.1±0.07 versus P30 WT 0.8±0.04 g/mg wet tissue | T test, p = 0.0023 |
| U46619 | P16 MFS 0.77±0.23 versus P16 WT 0.73±0.24 g/mg wet tissue | T test, p = 0.8076 |
| KCl (60 mm) | P16 MFS 0.17±0.02 versus P16 WT 0.21±0.03 g/mg wet tissue | T test, p = 0.2264 |
| PE | P16 MFS 292.4±28.07 versus P16 WT 178.4±31.05% | T test, p = 0.0139 |
| Stimulus | EC50 | Statistic |
|---|---|---|
| ACh | P16 MFS −6.9±0.08 versus P16 WT −7.4±0.06 logM | T test, p < 0.0001 |
| ACh | P30 MFS −6.7±0.21 versus P30 WT −7.6±0.27 logM | T test, p < 0.0001 |
| ACh | P30 MFS −6.7±0.21 versus P16 MFS −6.9±0.37 logM | T test, p = 0.0954 |
| SNP | P16 MFS −8.4±0.31 versus P16 WT −8.9±0.28 logM | T test, p = 0.0066 |
| SNP | P30 MFS −8.2±0.14 versus P30 WT 8.4±0.11 logM | T test, p = 0.3264 |
| PE | P16 MFS −6.7±0.37 versus P16 WT −6.5±0.26 logM | T test, p = 0.0843 |
| U46619 | P16 MFS −8.306±0.2687 versus P16 WT −8.064±0.2756 logM | T test, p = 0.1772 |
SNP, sodium nitroprusside.